XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa

Press/Media

Period23 Oct 2019

Media coverage

1

Media coverage

  • TitleXBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
    Media name/outletPrimeNewswire (Top News)
    Country/TerritoryUnited States
    Date23/10/19
    PersonsAlice Gottlieb
View all 1
View less